You are here: Home » Current Affairs » Coronavirus » News
SC refuses to entertain PIL against appointment of acting DGP in Jharkhand
India Coronavirus Dispatch: Time to rethink, transform our cities
Business Standard

Gauhati Medical College selected for COVAXIN 2nd phase clinical testing

The Gauhati Medical College and Hospital (GMCH) has been selected for the second phase clinical testing of India's indigenously developed coronavirus vaccine, COVAXIN

Topics
Coronavirus Vaccine | Coronavirus | Assam

IANS  |  Guwahati 



Coronavirus, Coronavirus tests

The Gauhati Medical College and Hospital (GMCH) has been selected for the second phase clinical testing of India's indigenously developed vaccine, COVAXIN, Health Minister Himanta Biswa Sarma said on Tuesday.

He said the GMCH would provide all-out support for the second phase clinical testing of COVAXIN, which has already shown successful results in phase-one clinical trials.

According to the Minister, till Tuesday night, has tested more than 18.22 lakh samples with 79,667 people testing positive for Covid-19. Of the total cases, 56,734 people have recovered from the disease with the recovery rate being 71.2 per cent and mortality rate 0.25 per cent.

Sarma said 197 people have died due to Covid-19 in the state so far. In terms of recovery rate, he said, five states -- Delhi, Tamil Nadu, Gujarat, West Bengal and Tripura -- were better than .

--IANS

sc/khz

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Wed, August 19 2020. 14:09 IST

RECOMMENDED FOR YOU